Merck KGaA (BIT:1MRK)
Italy · Delayed Price · Currency is EUR 125.15
-0.90 (-0.71%)
At close: Feb 11, 2026
Revenue
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 | Dec '15 Dec 31, 2015 | Dec '14 Dec 31, 2014 | Dec '13 Dec 31, 2013 | Dec '12 Dec 31, 2012 |
Process Solutions Revenue | 3.75B | 3.52B | 3.78B | |||||||||||
Process Solutions Revenue Growth | 6.49% | -6.87% | -16.69% | |||||||||||
Life Science Services Revenue | 691.80M | 721.80M | 792.20M | |||||||||||
Life Science Services Revenue Growth | -4.16% | -8.89% | -15.96% | |||||||||||
Science & Lab Solutions Revenue | 4.59B | 4.67B | 4.71B | |||||||||||
Science & Lab Solutions Revenue Growth | -1.80% | -0.73% | -3.91% | |||||||||||
Life Science Revenue | 9.03B | 8.92B | 9.28B | |||||||||||
Life Science Revenue Growth | 1.28% | -3.93% | -10.60% | |||||||||||
Oncology Revenue | 1.98B | 2.01B | 1.82B | |||||||||||
Oncology Revenue Growth | -1.49% | 10.47% | 8.12% | |||||||||||
Neurology & Immunology Revenue | 1.67B | 1.69B | 1.67B | |||||||||||
Neurology & Immunology Revenue Growth | -0.99% | 1.39% | -4.49% | |||||||||||
Fertility Revenue | 1.47B | 1.53B | 1.55B | |||||||||||
Fertility Revenue Growth | -3.56% | -1.27% | 7.01% | |||||||||||
Cardiovascular, Metabolism and Endocrinology Revenue | 3.03B | 2.95B | 2.79B | |||||||||||
Cardiovascular, Metabolism and Endocrinology Revenue Growth | 2.76% | 5.83% | -0.68% | |||||||||||
Other Healthcare Revenue | 315.50M | 280.50M | 235.40M | |||||||||||
Other Healthcare Revenue Growth | 12.48% | 19.16% | 45.85% | |||||||||||
Healthcare Revenue | 8.56B | 8.45B | 8.05B | |||||||||||
Healthcare Revenue Growth | 1.19% | 4.98% | 2.74% | |||||||||||
Display Solutions Revenue | 770.20M | 748.30M | 769.60M | |||||||||||
Display Solutions Revenue Growth | 2.93% | -2.77% | -14.45% | |||||||||||
Surface Solutions Revenue | 342.00M | 406.50M | 410.90M | |||||||||||
Surface Solutions Revenue Growth | -15.87% | -1.07% | -6.49% | |||||||||||
Semiconductor Solutions Revenue | 2.57B | 2.63B | 2.48B | |||||||||||
Semiconductor Solutions Revenue Growth | -2.15% | 6.13% | -7.32% | |||||||||||
Electronics Revenue | 3.69B | 3.79B | 3.66B | |||||||||||
Electronics Revenue Growth | -2.63% | 3.45% | -8.82% |
Revenue by Geography
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 | Dec '15 Dec 31, 2015 | Dec '14 Dec 31, 2014 | Dec '13 Dec 31, 2013 | Dec '12 Dec 31, 2012 |
Europe Revenue | 6.39B | 6.17B | 6.04B | |||||||||||
Europe Revenue Growth | 3.55% | 2.21% | -3.37% | |||||||||||
North America Revenue | 5.60B | 5.71B | 5.95B | |||||||||||
North America Revenue Growth | -1.89% | -4.06% | -6.44% | |||||||||||
Asia Pacific Revenue | 7.05B | 7.02B | 6.94B | |||||||||||
Asia Pacific Revenue Growth | 0.48% | 1.18% | -9.89% | |||||||||||
Latin America Revenue | 1.43B | 1.48B | 1.33B | |||||||||||
Latin America Revenue Growth | -2.92% | 10.91% | 8.14% | |||||||||||
Middle East & Africa Revenue | 795.30M | 781.20M | 737.10M | |||||||||||
Middle East & Africa Revenue Growth | 1.80% | 5.98% | 6.06% |
EBITDA
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 | Dec '15 Dec 31, 2015 | Dec '14 Dec 31, 2014 | Dec '13 Dec 31, 2013 | Dec '12 Dec 31, 2012 |
Life Science EBITDA | 2.61B | 2.59B | 2.82B | |||||||||||
Life Science EBITDA Growth | 0.69% | -8.17% | -25.00% | |||||||||||
Healthcare EBITDA | 3.13B | 2.99B | 2.54B | |||||||||||
Healthcare EBITDA Growth | 4.46% | 17.75% | 2.69% | |||||||||||
Electronics EBITDA | 856.40M | 969.60M | 913.00M | |||||||||||
Electronics EBITDA Growth | -11.68% | 6.20% | -23.42% | |||||||||||
Corporate/Others EBITDA | -434.20M | -481.80M | -396.70M |
Updated Sep 30, 2025. Data Source: Fiscal.ai.